VEGFA and diabetic macular edema: • Intravitreal anti-vascular endothelial growth factor (VEGF) therapy is the standard of care for patients with diabetic macular edema (DME); however, the burden of frequent injections is a key reason why real-world vision outcomes are often inferior to those reported in clinical trials.